Denali regains full rights to brain therapy after Takeda ends partnership

Go back to Denali regains full rights to brain therapy after Takeda ends partnership
(NASDAQ: DNLI) Delayed: 23.31 --0 (-0%)
Previous Close $23.31    52 Week High
Open $23.31    52 Week Low
Day High $23.31    P/E N/A 
Day Low $23.31    EPS
Volume 3,530